Pfizer Korea, top sponsor of clinical trials in 2012

Published: 2013-02-12 07:00:00

Updated: 2013-02-12 07:00:00

Pfizer Korea led any other companies in the number of clinical trials approved last year, according to the Korea Food and Drug Administration (KFDA).

The KFDA approved 46 clinical trials requested by Pfizer Korea.

Novartis Korea and received the KFDA’s approval for 30 clinical trials.

Q...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK